Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment
Modrego PJ.. Current Alzheimer research, 2006-04-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Results There is a substantial body of literature dealing with predictors of dementia in patients with MCI. The presence of the APOE epsilon 4 allele has been associated with increased risk of conversion but the sensitivity is quite low. CSF biochemical markers are being developed with encouraging results. beta-amyloid 42 protein is usually lower in converters than in people with stable cognitive status and tau protein is higher.
What this study adds
Evidence grade: Low
This is a narrative review. This review describes predictors that may help identify which people with mild cognitive impairment will go on to develop Alzheimer's dementia. It reports that APOE epsilon 4 raises conversion risk but with low sensitivity, and that CSF markers such as beta-amyloid 42 and tau are still being developed.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Modrego, P. J. (2006). Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Current Alzheimer research. https://doi.org/10.2174/156720506776383103
Vancouver
Modrego PJ. Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Current Alzheimer research. 2006. doi:10.2174/156720506776383103. PMID: 16611017.
BibTeX
@article{modrego2006-16611017,
author = {Modrego, P. J.},
title = {{Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment}},
journal = {Current Alzheimer research},
year = {2006},
doi = {10.2174/156720506776383103},
pmid = {16611017},
url = {https://doi.org/10.2174/156720506776383103}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results There is a substantial body of literature dealing with predictors of dementia in patients with MCI.
- The presence of the APOE epsilon 4 allele has been associated with increased risk of conversion but the sensitivity is quite low.
- CSF biochemical markers are being developed with encouraging results. beta-amyloid 42 protein is usually lower in converters than in people with stable cognitive status and tau protein is higher.
Why it matters
This review describes predictors that may help identify which people with mild cognitive impairment will go on to develop Alzheimer's dementia. It reports that APOE epsilon 4 raises conversion risk but with low sensitivity, and that CSF markers such as beta-amyloid 42 and tau are still being developed.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 37/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Current Alzheimer research) |
| Journal's citation record | 1 / 4 | Current Alzheimer Research: journal h-index 119 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2006 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 105 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.8 citations a year over 22 year(s) since 2006 |
| Impact for its field and year | 3 / 6 | Cited 6.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 12 other studies in this library |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Pedro J. Modrego: h-index 32 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Hospital Universitario Miguel Servet: institution h-index 257 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 16611017) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Later studies that cite this one
12 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Genetics from nearby years
Also tagged “mini-mental”
840 studies in the library carry the topic tag “mini-mental”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.